- Corporate Officers - G
- Gowen Maxine
Insider Trading History of Gowen Maxine
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gowen Maxine since 2011.
This trader's CIK number is 1280044.
At the time of last reporting, Gowen Maxine was the Officer of Aclaris Therapeutics, Inc.. (stock ticker symbol ACRS).
Also see all insider trading activities at Aclaris Therapeutics, Inc..
Note that in the past
GOWEN MAXINE also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Akebia Therapeutics, Inc. (AKBA) by Gowen Maxine
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | AKBA | 0 | $0 | 4,567 | $55,032 | 0 | $0 |
| 2014 | AKBA | 1,300 | $15,364 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aceragen, Inc. (ACGN) by Gowen Maxine
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | ACGN | 0 | $0 | 51 | $26 | 0 | $0 |
| 2016 | ACGN | 4,102 | $10,501 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aclaris Therapeutics, Inc. (ACRS) by Gowen Maxine
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | ACRS | 0 | $0 | 0 | $0 | 4,660 | $0 |
| 2023 | ACRS | 0 | $0 | 0 | $0 | 4,507 | $0 |
| 2022 | ACRS | 0 | $0 | 0 | $0 | 3,356 | $0 |
| 2020 | ACRS | 0 | $0 | 0 | $0 | 4,438 | $0 |
Yearly summary of insider trading at Human Genome Sciences Inc (HGSI) by Gowen Maxine
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | HGSI | 0 | $0 | 7,926 | $216,292 | 0 | $0 |
Yearly summary of insider trading at Trevena Inc (TRVN) by Gowen Maxine
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | TRVN | 50,000 | $51,000 | 0 | $0 | 0 | $0 |
| 2017 | TRVN | 0 | $0 | 0 | $0 | 110,403 | $75,294 |
| 2016 | TRVN | 34,584 | $208,523 | 0 | $0 | 0 | $0 |
| 2014 | TRVN | 8,000 | $32,000 | 0 | $0 | 124,477 | $84,893 |
Insider trading activities at 5 companies by Gowen Maxine:
1. Akebia Therapeutics, Inc. (AKBA)
2. Aceragen, Inc. (ACGN)
3. Aclaris Therapeutics, Inc. (ACRS)
4. Human Genome Sciences Inc (HGSI)
5. Trevena Inc (TRVN)
Table 1. Insider trading of Akebia Therapeutics, Inc. (AKBA) by Gowen Maxine
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-06-08 | AKBA | Sale | 4,567 | 12.05 | 55,032 |
| 2014-11-13 | AKBA | Buy | 1,300 | 11.82 | 15,364 |
Table 2. Insider trading of Aceragen, Inc. (ACGN) by Gowen Maxine
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-08-10 | ACGN | Sale | 51 | .51 | 26 |
| 2016-10-03 | IDRA | Buy | 4,102 | 2.56 | 10,501 |
Table 3. Insider trading of Aclaris Therapeutics, Inc. (ACRS) by Gowen Maxine
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-06-01 | ACRS | Option Ex | 4,660 | .00 | 0 |
| 2023-06-02 | ACRS | Option Ex | 4,507 | .00 | 0 |
| 2022-06-03 | ACRS | Option Ex | 3,356 | .00 | 0 |
| 2020-03-02 | ACRS | Option Ex | 4,438 | .00 | 0 |
Table 4. Insider trading of Human Genome Sciences Inc (HGSI) by Gowen Maxine
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-03-21 | HGSI | Sale | 7,926 | 27.29 | 216,292 |
Table 5. Insider trading of Trevena Inc (TRVN) by Gowen Maxine
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-02-01 | TRVN | Buy | 50,000 | 1.02 | 51,000 |
| 2017-02-23 | TRVN | Option Ex | 110,403 | .68 | 75,294 |
| 2016-11-07 | TRVN | Buy | 12,500 | 4.10 | 51,249 |
| 2016-05-26 | TRVN | Buy | 8,000 | 7.20 | 57,560 |
| 2016-05-27 | TRVN | Buy | 14,084 | 7.08 | 99,714 |
| 2014-12-10 | TRVN | Buy | 8,000 | 4.00 | 32,000 |
| 2014-04-23 | TRVN | Option Ex | 124,477 | .68 | 84,893 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Gowen Maxine
(Officer of Aclaris Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.